Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | RANTES | 61.5 | 62 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | RANTES | 120.0 | 67 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | RANTES | 74.0 | 40 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | RANTES | 100.0 | 76 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 107.0 | 56 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 109.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 71.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 166.0 | 50 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 136.0 | 71 | |
N2586 | IL-17A | 100 | ng/mL | 1 | RANTES | 138.0 | 57 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 117.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 70.0 | 69 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 149.5 | 84 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 150.0 | 58 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | RANTES | 92.5 | 60 | |
RA2159 | 1 | RANTES | 247.0 | 55 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | RANTES | 106.0 | 74 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | RANTES | 77.0 | 61 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | RANTES | 215.0 | 60 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | RANTES | 74.0 | 57 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | RANTES | 83.0 | 63 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | RANTES | 110.0 | 61 | ||||
N2586 | 1 | RANTES | 72.0 | 54 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | RANTES | 112.5 | 44 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | RANTES | 81.0 | 49 |